Raily Aesthetic Medicine International Holdings Past Earnings Performance
Past criteria checks 0/6
Raily Aesthetic Medicine International Holdings's earnings have been declining at an average annual rate of -70.2%, while the Healthcare industry saw earnings growing at 4.8% annually. Revenues have been growing at an average rate of 1.2% per year.
Key information
-70.2%
Earnings growth rate
-70.6%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 1.2% |
| Return on equity | -28.5% |
| Net Margin | -17.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Raily Aesthetic Medicine International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 189 | -32 | 92 | 2 |
| 30 Sep 23 | 179 | -26 | 88 | 2 |
| 30 Jun 23 | 168 | -20 | 84 | 2 |
| 31 Mar 23 | 166 | -18 | 84 | 2 |
| 31 Dec 22 | 165 | -16 | 85 | 2 |
| 30 Sep 22 | 178 | -13 | 88 | 1 |
| 30 Jun 22 | 191 | -11 | 90 | 0 |
| 31 Mar 22 | 190 | -14 | 90 | 0 |
| 31 Dec 21 | 188 | -18 | 89 | 0 |
| 30 Sep 21 | 193 | -3 | 83 | 0 |
| 30 Jun 21 | 197 | 11 | 77 | 0 |
| 31 Mar 21 | 181 | 8 | 73 | 0 |
| 31 Dec 20 | 165 | 4 | 70 | 0 |
| 30 Sep 20 | 161 | 0 | 70 | 0 |
| 30 Jun 20 | 158 | -4 | 69 | 0 |
| 31 Mar 20 | 174 | 3 | 69 | 0 |
| 31 Dec 19 | 191 | 10 | 68 | 0 |
| 31 Dec 18 | 159 | 18 | 63 | 0 |
| 31 Dec 17 | 113 | 17 | 49 | 0 |
Quality Earnings: 2930 is currently unprofitable.
Growing Profit Margin: 2930 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2930 is unprofitable, and losses have increased over the past 5 years at a rate of 70.2% per year.
Accelerating Growth: Unable to compare 2930's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2930 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).
Return on Equity
High ROE: 2930 has a negative Return on Equity (-28.49%), as it is currently unprofitable.